National Institute of Arthritis and Musculoskeletal and Skin Diseases
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3)
Deadline
March 4, 2027
Eligibility
Foreign components allowed
Funding Amount
Unlock to view
Grant Overview
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3) is a research funding opportunity offered by National Institute of Arthritis and Musculoskeletal and Skin Diseases covering areas such as Clinical Trials, Musculoskeletal Research, Skin Diseases for applicants in Foreign components allowed. The application deadline is March 4, 2027.
Researchers, universities, institutions and eligible organizations should review the funder requirements, geographic eligibility, research focus and deadline before preparing an application.
Focus Areas
Geographic Eligibility
- •Foreign components allowed
Before You Apply
Confirm the final deadline, applicant requirements, funding conditions and submission instructions on the official funder website before submitting an application.